Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development

Ming Chang Hsieh, Hui Ting Hsu, Pei Ching Hsiao, Shun Fa Yang, Chao Bin Yeh, Mauo Ying Bien, Chien-Huang Lin, Ming Hsien Chien

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Vascular endothelial growth factor C (VEGF-C), an angiogenic/lymphangiogenic factor with high expression levels in tumor tissues, plays important roles in the development of several malignancies including hepatocellular carcinoma (HCC). The purpose of this study was to examine whether VEGF-C gene polymorphisms are associated with susceptibility to HCC and its clinicopathological development. Methods: Genetic polymorphisms of VEGF-C of 135 patients with HCC and 520 noncancer controls were analyzed by a real-time polymerase chain reaction (PCR). Results: We found that a significantly (P = 0.021) higher risk for HCC was shown in individuals with the VEGF-C rs1485766 A/A genotype compared to those with wild-type homozygotes; a high frequency of an advanced stage and a low frequency of being positive for cirrhosis were respectively shown in HCC patients with the VEGF-C rs7664413 CT/TT and rs3775194 GC/CC genotypes. Moreover, we found that the GGACA, GACTG, CGATG, and GGCTG haplotypes of five VEGF-C single-nucleotide polymorphisms (SNPs) combined were also related to the risk of HCC. Conclusions: Our results suggest that the VEGF-C rs1485766 SNP and either of five haplotypes combined might contribute to a prediction of susceptibility to HCC. The genetic polymorphism of VEGF-C rs7664413 might be a predictive factor for advanced-stage HCC.

Original languageEnglish
Pages (from-to)237-244
Number of pages8
JournalJournal of Clinical Laboratory Analysis
Volume28
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Vascular Endothelial Growth Factor C
Polymorphism
Hepatocellular Carcinoma
Genes
Genetic Polymorphisms
Haplotypes
Single Nucleotide Polymorphism
Nucleotides
Genotype
Angiogenesis Inducing Agents
Polymerase chain reaction
Homozygote
Tumors
Real-Time Polymerase Chain Reaction
Neoplasms
Fibrosis
Tissue

Keywords

  • Hepatocellular carcinoma
  • Single-nucleotide polymorphism
  • Vascular endothelial growth factor C

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Public Health, Environmental and Occupational Health
  • Hematology
  • Immunology and Allergy
  • Microbiology (medical)
  • Medical Laboratory Technology
  • Medicine(all)

Cite this

Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development. / Hsieh, Ming Chang; Hsu, Hui Ting; Hsiao, Pei Ching; Yang, Shun Fa; Yeh, Chao Bin; Bien, Mauo Ying; Lin, Chien-Huang; Chien, Ming Hsien.

In: Journal of Clinical Laboratory Analysis, Vol. 28, No. 3, 2014, p. 237-244.

Research output: Contribution to journalArticle

Hsieh, Ming Chang ; Hsu, Hui Ting ; Hsiao, Pei Ching ; Yang, Shun Fa ; Yeh, Chao Bin ; Bien, Mauo Ying ; Lin, Chien-Huang ; Chien, Ming Hsien. / Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development. In: Journal of Clinical Laboratory Analysis. 2014 ; Vol. 28, No. 3. pp. 237-244.
@article{fce0539ce10048489ad32eb9a5c41a98,
title = "Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development",
abstract = "Background: Vascular endothelial growth factor C (VEGF-C), an angiogenic/lymphangiogenic factor with high expression levels in tumor tissues, plays important roles in the development of several malignancies including hepatocellular carcinoma (HCC). The purpose of this study was to examine whether VEGF-C gene polymorphisms are associated with susceptibility to HCC and its clinicopathological development. Methods: Genetic polymorphisms of VEGF-C of 135 patients with HCC and 520 noncancer controls were analyzed by a real-time polymerase chain reaction (PCR). Results: We found that a significantly (P = 0.021) higher risk for HCC was shown in individuals with the VEGF-C rs1485766 A/A genotype compared to those with wild-type homozygotes; a high frequency of an advanced stage and a low frequency of being positive for cirrhosis were respectively shown in HCC patients with the VEGF-C rs7664413 CT/TT and rs3775194 GC/CC genotypes. Moreover, we found that the GGACA, GACTG, CGATG, and GGCTG haplotypes of five VEGF-C single-nucleotide polymorphisms (SNPs) combined were also related to the risk of HCC. Conclusions: Our results suggest that the VEGF-C rs1485766 SNP and either of five haplotypes combined might contribute to a prediction of susceptibility to HCC. The genetic polymorphism of VEGF-C rs7664413 might be a predictive factor for advanced-stage HCC.",
keywords = "Hepatocellular carcinoma, Single-nucleotide polymorphism, Vascular endothelial growth factor C",
author = "Hsieh, {Ming Chang} and Hsu, {Hui Ting} and Hsiao, {Pei Ching} and Yang, {Shun Fa} and Yeh, {Chao Bin} and Bien, {Mauo Ying} and Chien-Huang Lin and Chien, {Ming Hsien}",
year = "2014",
doi = "10.1002/jcla.21672",
language = "English",
volume = "28",
pages = "237--244",
journal = "Journal of Clinical Laboratory Analysis",
issn = "0887-8013",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development

AU - Hsieh, Ming Chang

AU - Hsu, Hui Ting

AU - Hsiao, Pei Ching

AU - Yang, Shun Fa

AU - Yeh, Chao Bin

AU - Bien, Mauo Ying

AU - Lin, Chien-Huang

AU - Chien, Ming Hsien

PY - 2014

Y1 - 2014

N2 - Background: Vascular endothelial growth factor C (VEGF-C), an angiogenic/lymphangiogenic factor with high expression levels in tumor tissues, plays important roles in the development of several malignancies including hepatocellular carcinoma (HCC). The purpose of this study was to examine whether VEGF-C gene polymorphisms are associated with susceptibility to HCC and its clinicopathological development. Methods: Genetic polymorphisms of VEGF-C of 135 patients with HCC and 520 noncancer controls were analyzed by a real-time polymerase chain reaction (PCR). Results: We found that a significantly (P = 0.021) higher risk for HCC was shown in individuals with the VEGF-C rs1485766 A/A genotype compared to those with wild-type homozygotes; a high frequency of an advanced stage and a low frequency of being positive for cirrhosis were respectively shown in HCC patients with the VEGF-C rs7664413 CT/TT and rs3775194 GC/CC genotypes. Moreover, we found that the GGACA, GACTG, CGATG, and GGCTG haplotypes of five VEGF-C single-nucleotide polymorphisms (SNPs) combined were also related to the risk of HCC. Conclusions: Our results suggest that the VEGF-C rs1485766 SNP and either of five haplotypes combined might contribute to a prediction of susceptibility to HCC. The genetic polymorphism of VEGF-C rs7664413 might be a predictive factor for advanced-stage HCC.

AB - Background: Vascular endothelial growth factor C (VEGF-C), an angiogenic/lymphangiogenic factor with high expression levels in tumor tissues, plays important roles in the development of several malignancies including hepatocellular carcinoma (HCC). The purpose of this study was to examine whether VEGF-C gene polymorphisms are associated with susceptibility to HCC and its clinicopathological development. Methods: Genetic polymorphisms of VEGF-C of 135 patients with HCC and 520 noncancer controls were analyzed by a real-time polymerase chain reaction (PCR). Results: We found that a significantly (P = 0.021) higher risk for HCC was shown in individuals with the VEGF-C rs1485766 A/A genotype compared to those with wild-type homozygotes; a high frequency of an advanced stage and a low frequency of being positive for cirrhosis were respectively shown in HCC patients with the VEGF-C rs7664413 CT/TT and rs3775194 GC/CC genotypes. Moreover, we found that the GGACA, GACTG, CGATG, and GGCTG haplotypes of five VEGF-C single-nucleotide polymorphisms (SNPs) combined were also related to the risk of HCC. Conclusions: Our results suggest that the VEGF-C rs1485766 SNP and either of five haplotypes combined might contribute to a prediction of susceptibility to HCC. The genetic polymorphism of VEGF-C rs7664413 might be a predictive factor for advanced-stage HCC.

KW - Hepatocellular carcinoma

KW - Single-nucleotide polymorphism

KW - Vascular endothelial growth factor C

UR - http://www.scopus.com/inward/record.url?scp=84899620962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899620962&partnerID=8YFLogxK

U2 - 10.1002/jcla.21672

DO - 10.1002/jcla.21672

M3 - Article

C2 - 24478168

AN - SCOPUS:84899620962

VL - 28

SP - 237

EP - 244

JO - Journal of Clinical Laboratory Analysis

JF - Journal of Clinical Laboratory Analysis

SN - 0887-8013

IS - 3

ER -